Skip to main content
Fig. 2 | Orphanet Journal of Rare Diseases

Fig. 2

From: Efficacy and safety of low-dose Sirolimus in Lymphangioleiomyomatosis

Fig. 2

Changes in lung function before and after treatment. Changes in FEV1 (a), DLco (b) and FVC (c) before and after treatment. Bars and lines show the mean ± standard error of changes in lung function. Abbreviations: Pre_12M, 12 months before treatment; Post_12M, 12 months after treatment; Post_24M, 24 months after treatment; FEV1, forced expiratory volume in 1 s; DLco, diffusing capacity of the lung for carbon monoxide; FVC, forced vital capacity. *p < 0.05

Back to article page